Fred Schwarzer - 14 May 2021 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
CEO and President, Director
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
14 May 2021
Net transactions value
+$14,367
Form type
4
Filing time
18 May 2021, 21:40:45 UTC
Next filing
17 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $14,367 +313 +23% $45.90* 1,700 14 May 2021 Direct F1, F2
holding IGMS Common Stock 196,718 14 May 2021 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 The number of shares held reflects the transfer by the Reporting Person, on February 17, 2021, of 196,718 shares to Fred M. Schwarzer & Deborah R. Schwarzer TTEES of the Schwarzer Family Trust U/A DTD 04/05/2018 (the "Schwarzer Family Trust").
F3 The shares are held by the Schwarzer Family Trust.